| Literature DB >> 34045484 |
Ehsan Valiey1, Mohammad G Dekamin2, Zahra Alirezvani1.
Abstract
This study introduces a practical approach to faEntities:
Year: 2021 PMID: 34045484 PMCID: PMC8159994 DOI: 10.1038/s41598-021-89572-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Scheme 1Schematic preparation of MCM-41-APS-PMDA-NHSO3H (1) for the three-component condensation of ethyl acetoacetate (2), aldehydes (3), urea (4) to afford 3,4-dihydropyrimidin-2-(1H)-one derivatives (5).
Figure 1FTIR spectra of the MCM-41 (a), MCM-41-APS (b), MCM-41-APS-PMDA (c) and MCM-41-APS-PMDA-NHSO3H (d) (1).
Figure 2FESEM images of the MCM-41 (a–c) and the MCM-41-APS-PMDA-NHSO3H (1, d–f) materials.
Figure 3TGA analysis of the MCM-41-APS-PMDA-NHSO3H materials (1).
Figure 4EDX spectra of the MCM-41-APS-PMDA-NHSO3H materials (1).
Figure 5Low angle (a) and wide angle (b) XRD patterns of the hybrid MCM-41-APS-PMDA-NHSO3H nanocatalyst (1).
Figure 6Adsorption/desorption isotherm of the MCM-41-APS-PMDA-NHSO3H nanocatalyst (1).
Optimization of conditions in the model reaction of ethyl acetoacetate (2), 4-chlorobenzaldehyde (3a), urea (4) under different conditions in the presence of MCM-41-APS-PMDA-NHSO3H (1).a
| Entry | Catalyst loading (mg) | Solvent | Temperature (°C) | Time (min) | Yieldb (%) |
|---|---|---|---|---|---|
| 1 | 20 | MeOH | r.t | 180 | 26 |
| 2 | 20 | EtOH | Reflux | 90 | 69 |
| 3 | 20 | CH2Cl2 | Reflux | 90 | 45 |
| 4 | 20 | CH3CN | 60 | 120 | 78 |
| 5 | 20 | DMF | Reflux | 100 | 62 |
| 6 | 20 | Toluene | Reflux | 150 | 48 |
| 7 | 20 | Et2O | r.t | 240 | 35 |
| 8 | 20 | CHCl3 | 60 | 120 | 75 |
| 9 | 20 | EtOH/H2O (1:2) | Reflux | 55 | 77 |
| 10 | 20 | EtOH/H2O (1:1) | Reflux | 70 | 73 |
| 11 | 15 | Solvent-free | 80 | 35 | 95 |
| 12 | 10 | Solvent-free | 80 | 65 | 69 |
| 13 | 5 | Solvent-free | 80 | 90 | 60 |
| 14 | 2 | Solvent-free | 80 | 120 | 57 |
| 15 | 0 | Solvent-free | 80 | 180 | 15 |
aReaction conditions: ethyl acetoacetate (2, 1 mmol), 4-chlorobenzaldehyde (3a, 1 mmol), urea (4, 1.2 mmol), MCM-41-APS-PMDA-NHSO3H (1) and solvent (2 ml, if not otherwise stated).
Scope of the Biginelli condensation for the synthesis of 3,4-dihydropyrimidin-2-(1H)-ones catalyzed by MCM-41-APS-PMDA-NHSO3H (1)a.
| Entry | Aldehyde 3 | Product 5 | Time (min) | Yield (%)b | mp °C (Obs.) | mp °C (Lit.) |
|---|---|---|---|---|---|---|
| 1 | 4-ClC6H4– |
| 35 | 95 | 210–211 | 210–211[ |
| 2 | C6H5– |
| 55 | 87 | 235–236 | 234–236[ |
| 3 | 4-NO2C6H4– |
| 50 | 80 | 204 | 224–227[ |
| 4 | 3-NO2C6H4– |
| 60 | 82 | 293–295 | 204[ |
| 5 | 4-CH3OC6H4– |
| 55 | 89 | 201–203 | 202–204[ |
| 6 | 2-ClC6H4– |
| 60 | 90 | 211–213 | 211–213[ |
| 7 | 4-OHC6H4– |
| 55 | 82 | 234–236 | 233–235[ |
| 8 | 2-C4H3S– |
| 45 | 84 | 212–214 | 210–212[ |
| 9 | 4-Me2NC6H4– |
| 45 | 92 | 213–215 | 213–215[ |
| 10 | 4-FC6H4– |
| 60 | 85 | 180 | 180[ |
| 11 | 4-OH-3-MeO-C6H3– |
| 40 | 84 | 188–190 | 188.5[ |
aReaction conditions: ethyl acetoacetate (2, 1 mmol), aldehydes (3a–k, 1 mmol), urea (4, 1.2 mmol), MCM-41-APS-PMDA-NHSO3H (1, 15 mg) under solvent-free conditions at 80 °C.
bIsolated yields were reported.
Scheme 2Proposed mechanism for the synthesis of 3,4-dihydropyrimidin-2(1H)-ones catalyzed by MCM-41 (MCM-41-APS-PMDA-NHSO3H (1).
Figure 7Reusability of the heterogeneous acidic nanocatalyst MCM-41-APS-PMDA-NHSO3H (1) for the synthesis of 5a.
Comparison of the catalytic activity of the MCM-41-APS-PMDA-NHSO3H (1) with other catalysts.
| Entry | Catalyst | Amount of catalyst loading | Solvent | Temp. (°C) | Time (min) | Yield (%) | References |
|---|---|---|---|---|---|---|---|
| 1 | PPF-SO3H | 250 mg | EtOH | Reflux | 480 | 81 | [ |
| 2 | PANI-FeCl3 | 200 mg | CH3CN | Reflux | 1440 | 83 | [ |
| 3 | Fe3O4/PAA-SO3H | 60 mg | Solvent-free | RT | 120 | 90 | [ |
| 4 | H2SO4.Silica gel | 30 mol ⁒(47 mg) | Solvent-free | 60 °C | 120 | 89 | [ |
| 5 | Zr(H2PO4)2 | 7 mol ⁒(20 mg) | Solvent-free | 90 °C | 60 | 92 | [ |
| 6 |